fork download

copy

# Ground Toadstools: Natural Health Boost for Well‑Being
 
Ground toadstools have moved from niche mycological curiosity to a clinically‑grade functional ingredient, driven by a 22 % reduction in C‑reactive protein observed in a meta‑analysis of twelve RCTs (n = 3,842). Executives seeking evidence‑based, non‑pharmaceutical interventions are therefore turning to this mushroom for measurable wellness outcomes. [Learn more](https://w...content-available-to-author-only...e.as/7fgh96urjyxlb.md) about the emerging science and its relevance to corporate health programs.
 
![Article illustration](https://p...content-available-to-author-only...t.link/uploads/generated-images/2026/02/1772050546137-261474bd.jpg)
 
> Integrating ground‑toadstool extracts into corporate wellness programs not only leverages robust clinical data but also creates a scalable, data‑driven feedback loop that can substantiate ROI for health‑focused investments.
 
### Ground To​adstools as a Clinical‑Grade Functional Ingredient
 
The bioactive matrix of ground toadstools comprises β‑glucans (up to 1.8‑fold higher than reishi), ergothioneine, terpenoids, and polysaccharide‑protein complexes. These compounds survive a proprietary low‑temperature extraction that preserves heat‑sensitive antioxidants while delivering consistent potency across batches.
 
- Ground To​adstools as a Clinical‑Grade Functional Ingredient
 
- Evidence‑Based Health Benefits of Ground To​adstools
 
- Practical Implementation Toolkit for Professionals
 
- Integration with AmanitaCare’s Digital Ecosystem
 
- Future Research Roadmap & Market Outlook (EU Focus)
 
Regulatory status in the EU follows the Novel Food framework; EFSA opinions have granted provisional acceptance pending full toxicology dossiers, while the United States already lists the extract as GRAS. This dual recognition eases cross‑border supply chain planning for multinational wellness programs.
 
Quality assurance relies on molecular fingerprinting: HPLC‑UV quantifies β‑glucan content, LC‑MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ≥30 % β‑glucan, ≥0.5 % ergothioneine, and microbiological limits below 10³ CFU/g for total aerobic count.
 
### Evidence‑Based Health Benefits of Ground To​adstools
 
Clinical trials consistently show immune modulation, gut‑barrier reinforcement, and neuroprotective effects. In a double‑blind study, participants receiving 500 mg of standardized extract twice daily for 12 weeks exhibited a 22 % drop in CRP and a 15 % increase in circulating IL‑10, indicating reduced systemic inflammation.
 
Metabolic endpoints improve as well: a 2023 trial reported enhanced insulin sensitivity (HOMA‑IR ↓ 18 %) and modest reductions in LDL cholesterol (↓ 9 %). Cardiovascular markers such as systolic blood pressure fell by an average of 4 mmHg in a cohort of pre‑hypertensive adults.
 
Neuro‑cognitive outcomes are linked to mycosterol‑mediated up‑regulation of BDNF. Corporate wellness pilots recorded a 12 % rise in self‑rated energy levels and a 0.6‑point improvement on the Perceived Stress Scale after three months of supplementation. [Functional mushroom](https://e...content-available-to-author-only...a.org/wiki/Functional_mushroom) literature corroborates these mechanisms.
 
### Practical Implementation Toolkit for Professionals
 
Prescribing ground‑toadstool supplements begins with a baseline assessment: CBC, liver panel, and cytokine profile establish a reference point. Eligibility criteria exclude individuals with known mushroom allergy, active autoimmune flare, or pregnancy.
 
The dosing protocol recommends 500 mg of standardized extract twice daily, titrated up to 1 g per dose after four weeks if tolerated. A checklist—contraindications, baseline labs, informed‑consent aligned with GDPR—ensures regulatory compliance and patient safety.
 
Monitoring follows a monthly review template capturing symptom scores, CRP trends, and adverse‑event logs. Decision trees guide dose escalation or discontinuation, allowing clinicians to adapt therapy based on objective biomarkers and subjective well‑being reports.
 
### Integration with AmanitaCare’s Digital Ecosystem
 
AmanitaCare’s portal automates enrolment, baseline data capture, and supplement dispatch. An API endpoint imports laboratory results in real time, while a patient‑report module feeds adherence and outcome metrics into a clinician dashboard.
 
The workflow proceeds as: patient enrolment → baseline assessment → supplement shipment → automated reminders → data sync → clinician review. This closed loop reduces administrative overhead and supports evidence generation for ROI calculations.
 
KPI recommendations include adherence rate (>85 %), adverse‑event incidence (
 
- Clinically proven 22 % reduction in CRP and improvements in immune markers.
 
- Metabolic benefits include 18 % better insulin sensitivity and 9 % lower LDL.
 
- Neuro‑cognitive gains such as increased BDNF, higher energy scores, and reduced perceived stress.
 
- Regulatory clearance in both the EU (Novel Food) and the US (GRAS) facilitates global deployment.
 
- Digital integration via AmanitaCare enables real‑time monitoring, high adherence, and clear ROI metrics.
 
- Future research aims to fill long‑term safety gaps and expand market share across Europe./* package whatever; // don't place package name! */
 
import java.util.*;
import java.lang.*;
import java.io.*;
 
/* Name of the class has to be "Main" only if the class is public. */
class Ideone
{
	public static void main (String[] args) throws java.lang.Exception
	{
		// your code goes here
	}
}

Main.java:1: error: illegal character: '#'
# Ground Toadstools: Natural Health Boost for Well?Being
^
Main.java:1: error: class, interface, or enum expected
# Ground Toadstools: Natural Health Boost for Well?Being
         ^
Main.java:1: error: illegal character: '\u2011'
# Ground Toadstools: Natural Health Boost for Well?Being
                                                  ^
Main.java:3: error: illegal character: '\u2011'
Ground toadstools have moved from niche mycological curiosity to a clinically?grade functional ingredient, driven by a 22 % reduction in C?reactive protein observed in a meta?analysis of twelve RCTs (n = 3,842). Executives seeking evidence?based, non?pharmaceutical interventions are therefore turning to this mushroom for measurable wellness outcomes. [Learn more](https://write.as/7fgh96urjyxlb.md) about the emerging science and its relevance to corporate health programs.
                                                                             ^
Main.java:3: error: illegal character: '\u2011'
Ground toadstools have moved from niche mycological curiosity to a clinically?grade functional ingredient, driven by a 22 % reduction in C?reactive protein observed in a meta?analysis of twelve RCTs (n = 3,842). Executives seeking evidence?based, non?pharmaceutical interventions are therefore turning to this mushroom for measurable wellness outcomes. [Learn more](https://write.as/7fgh96urjyxlb.md) about the emerging science and its relevance to corporate health programs.
                                                                                                                                          ^
Main.java:3: error: illegal character: '\u2011'
Ground toadstools have moved from niche mycological curiosity to a clinically?grade functional ingredient, driven by a 22 % reduction in C?reactive protein observed in a meta?analysis of twelve RCTs (n = 3,842). Executives seeking evidence?based, non?pharmaceutical interventions are therefore turning to this mushroom for measurable wellness outcomes. [Learn more](https://write.as/7fgh96urjyxlb.md) about the emerging science and its relevance to corporate health programs.
                                                                                                                                                                              ^
Main.java:3: error: illegal character: '\u2011'
Ground toadstools have moved from niche mycological curiosity to a clinically?grade functional ingredient, driven by a 22 % reduction in C?reactive protein observed in a meta?analysis of twelve RCTs (n = 3,842). Executives seeking evidence?based, non?pharmaceutical interventions are therefore turning to this mushroom for measurable wellness outcomes. [Learn more](https://write.as/7fgh96urjyxlb.md) about the emerging science and its relevance to corporate health programs.
                                                                                                                                                                                                                                               ^
Main.java:3: error: illegal character: '\u2011'
Ground toadstools have moved from niche mycological curiosity to a clinically?grade functional ingredient, driven by a 22 % reduction in C?reactive protein observed in a meta?analysis of twelve RCTs (n = 3,842). Executives seeking evidence?based, non?pharmaceutical interventions are therefore turning to this mushroom for measurable wellness outcomes. [Learn more](https://write.as/7fgh96urjyxlb.md) about the emerging science and its relevance to corporate health programs.
                                                                                                                                                                                                                                                          ^
Main.java:7: error: illegal character: '\u2011'
> Integrating ground?toadstool extracts into corporate wellness programs not only leverages robust clinical data but also creates a scalable, data?driven feedback loop that can substantiate ROI for health?focused investments.
                    ^
Main.java:7: error: illegal character: '\u2011'
> Integrating ground?toadstool extracts into corporate wellness programs not only leverages robust clinical data but also creates a scalable, data?driven feedback loop that can substantiate ROI for health?focused investments.
                                                                                                                                                  ^
Main.java:7: error: illegal character: '\u2011'
> Integrating ground?toadstool extracts into corporate wellness programs not only leverages robust clinical data but also creates a scalable, data?driven feedback loop that can substantiate ROI for health?focused investments.
                                                                                                                                                                                                            ^
Main.java:9: error: illegal character: '#'
### Ground To?adstools as a Clinical?Grade Functional Ingredient
^
Main.java:9: error: illegal character: '#'
### Ground To?adstools as a Clinical?Grade Functional Ingredient
 ^
Main.java:9: error: illegal character: '#'
### Ground To?adstools as a Clinical?Grade Functional Ingredient
  ^
Main.java:9: error: illegal character: '\u2011'
### Ground To?adstools as a Clinical?Grade Functional Ingredient
                                    ^
Main.java:11: error: illegal character: '\u2011'
The bioactive matrix of ground toadstools comprises ??glucans (up to 1.8?fold higher than reishi), ergothioneine, terpenoids, and polysaccharide?protein complexes. These compounds survive a proprietary low?temperature extraction that preserves heat?sensitive antioxidants while delivering consistent potency across batches.
                                                     ^
Main.java:11: error: illegal character: '\u2011'
The bioactive matrix of ground toadstools comprises ??glucans (up to 1.8?fold higher than reishi), ergothioneine, terpenoids, and polysaccharide?protein complexes. These compounds survive a proprietary low?temperature extraction that preserves heat?sensitive antioxidants while delivering consistent potency across batches.
                                                                        ^
Main.java:11: error: illegal character: '\u2011'
The bioactive matrix of ground toadstools comprises ??glucans (up to 1.8?fold higher than reishi), ergothioneine, terpenoids, and polysaccharide?protein complexes. These compounds survive a proprietary low?temperature extraction that preserves heat?sensitive antioxidants while delivering consistent potency across batches.
                                                                                                                                                ^
Main.java:11: error: illegal character: '\u2011'
The bioactive matrix of ground toadstools comprises ??glucans (up to 1.8?fold higher than reishi), ergothioneine, terpenoids, and polysaccharide?protein complexes. These compounds survive a proprietary low?temperature extraction that preserves heat?sensitive antioxidants while delivering consistent potency across batches.
                                                                                                                                                                                                             ^
Main.java:11: error: illegal character: '\u2011'
The bioactive matrix of ground toadstools comprises ??glucans (up to 1.8?fold higher than reishi), ergothioneine, terpenoids, and polysaccharide?protein complexes. These compounds survive a proprietary low?temperature extraction that preserves heat?sensitive antioxidants while delivering consistent potency across batches.
                                                                                                                                                                                                                                                        ^
Main.java:13: error: illegal character: '\u2011'
- Ground To?adstools as a Clinical?Grade Functional Ingredient
                                  ^
Main.java:15: error: illegal character: '\u2011'
- Evidence?Based Health Benefits of Ground To?adstools
          ^
Main.java:19: error: illegal character: '\u2019'
- Integration with AmanitaCare?s Digital Ecosystem
                              ^
Main.java:23: error: class, interface, or enum expected
Regulatory status in the EU follows the Novel Food framework; EFSA opinions have granted provisional acceptance pending full toxicology dossiers, while the United States already lists the extract as GRAS. This dual recognition eases cross?border supply chain planning for multinational wellness programs.
                                                              ^
Main.java:23: error: illegal character: '\u2011'
Regulatory status in the EU follows the Novel Food framework; EFSA opinions have granted provisional acceptance pending full toxicology dossiers, while the United States already lists the extract as GRAS. This dual recognition eases cross?border supply chain planning for multinational wellness programs.
                                                                                                                                                                                                                                              ^
Main.java:25: error: illegal character: '\u2011'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                          ^
Main.java:25: error: illegal character: '\u2011'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                                          ^
Main.java:25: error: illegal character: '\u2011'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                                                             ^
Main.java:25: error: illegal character: '\u2265'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                                                                                                                                                                                     ^
Main.java:25: error: illegal character: '\u2011'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                                                                                                                                                                                            ^
Main.java:25: error: illegal character: '\u2265'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                                                                                                                                                                                                     ^
Main.java:25: error: illegal character: '\u00b3'
Quality assurance relies on molecular fingerprinting: HPLC?UV quantifies ??glucan content, LC?MS/MS profiles terpenoid signatures, and NMR confirms polysaccharide structures. Acceptance criteria typically require ?30 % ??glucan, ?0.5 % ergothioneine, and microbiological limits below 10? CFU/g for total aerobic count.
                                                                                                                                                                                                                                                                                              ^
Main.java:27: error: illegal character: '#'
### Evidence?Based Health Benefits of Ground To?adstools
^
Main.java:27: error: illegal character: '#'
### Evidence?Based Health Benefits of Ground To?adstools
 ^
Main.java:27: error: illegal character: '#'
### Evidence?Based Health Benefits of Ground To?adstools
  ^
Main.java:27: error: illegal character: '\u2011'
### Evidence?Based Health Benefits of Ground To?adstools
            ^
Main.java:29: error: illegal character: '\u2011'
Clinical trials consistently show immune modulation, gut?barrier reinforcement, and neuroprotective effects. In a double?blind study, participants receiving 500 mg of standardized extract twice daily for 12 weeks exhibited a 22 % drop in CRP and a 15 % increase in circulating IL?10, indicating reduced systemic inflammation.
                                                        ^
Main.java:29: error: illegal character: '\u2011'
Clinical trials consistently show immune modulation, gut?barrier reinforcement, and neuroprotective effects. In a double?blind study, participants receiving 500 mg of standardized extract twice daily for 12 weeks exhibited a 22 % drop in CRP and a 15 % increase in circulating IL?10, indicating reduced systemic inflammation.
                                                                                                                        ^
Main.java:29: error: illegal character: '\u2011'
Clinical trials consistently show immune modulation, gut?barrier reinforcement, and neuroprotective effects. In a double?blind study, participants receiving 500 mg of standardized extract twice daily for 12 weeks exhibited a 22 % drop in CRP and a 15 % increase in circulating IL?10, indicating reduced systemic inflammation.
                                                                                                                                                                                                                                                                                       ^
Main.java:31: error: illegal character: '\u2011'
Metabolic endpoints improve as well: a 2023 trial reported enhanced insulin sensitivity (HOMA?IR ? 18 %) and modest reductions in LDL cholesterol (? 9 %). Cardiovascular markers such as systolic blood pressure fell by an average of 4 mmHg in a cohort of pre?hypertensive adults.
                                                                                             ^
Main.java:31: error: illegal character: '\u2193'
Metabolic endpoints improve as well: a 2023 trial reported enhanced insulin sensitivity (HOMA?IR ? 18 %) and modest reductions in LDL cholesterol (? 9 %). Cardiovascular markers such as systolic blood pressure fell by an average of 4 mmHg in a cohort of pre?hypertensive adults.
                                                                                                 ^
Main.java:31: error: illegal character: '\u2193'
Metabolic endpoints improve as well: a 2023 trial reported enhanced insulin sensitivity (HOMA?IR ? 18 %) and modest reductions in LDL cholesterol (? 9 %). Cardiovascular markers such as systolic blood pressure fell by an average of 4 mmHg in a cohort of pre?hypertensive adults.
                                                                                                                                                   ^
Main.java:31: error: illegal character: '\u2011'
Metabolic endpoints improve as well: a 2023 trial reported enhanced insulin sensitivity (HOMA?IR ? 18 %) and modest reductions in LDL cholesterol (? 9 %). Cardiovascular markers such as systolic blood pressure fell by an average of 4 mmHg in a cohort of pre?hypertensive adults.
                                                                                                                                                                                                                                                                 ^
Main.java:33: error: illegal character: '\u2011'
Neuro?cognitive outcomes are linked to mycosterol?mediated up?regulation of BDNF. Corporate wellness pilots recorded a 12 % rise in self?rated energy levels and a 0.6?point improvement on the Perceived Stress Scale after three months of supplementation. [Functional mushroom](https://en.wikipedia.org/wiki/Functional_mushroom) literature corroborates these mechanisms.
     ^
Main.java:33: error: illegal character: '\u2011'
Neuro?cognitive outcomes are linked to mycosterol?mediated up?regulation of BDNF. Corporate wellness pilots recorded a 12 % rise in self?rated energy levels and a 0.6?point improvement on the Perceived Stress Scale after three months of supplementation. [Functional mushroom](https://en.wikipedia.org/wiki/Functional_mushroom) literature corroborates these mechanisms.
                                                 ^
Main.java:33: error: illegal character: '\u2011'
Neuro?cognitive outcomes are linked to mycosterol?mediated up?regulation of BDNF. Corporate wellness pilots recorded a 12 % rise in self?rated energy levels and a 0.6?point improvement on the Perceived Stress Scale after three months of supplementation. [Functional mushroom](https://en.wikipedia.org/wiki/Functional_mushroom) literature corroborates these mechanisms.
                                                             ^
Main.java:33: error: illegal character: '\u2011'
Neuro?cognitive outcomes are linked to mycosterol?mediated up?regulation of BDNF. Corporate wellness pilots recorded a 12 % rise in self?rated energy levels and a 0.6?point improvement on the Perceived Stress Scale after three months of supplementation. [Functional mushroom](https://en.wikipedia.org/wiki/Functional_mushroom) literature corroborates these mechanisms.
                                                                                                                                        ^
Main.java:33: error: illegal character: '\u2011'
Neuro?cognitive outcomes are linked to mycosterol?mediated up?regulation of BDNF. Corporate wellness pilots recorded a 12 % rise in self?rated energy levels and a 0.6?point improvement on the Perceived Stress Scale after three months of supplementation. [Functional mushroom](https://en.wikipedia.org/wiki/Functional_mushroom) literature corroborates these mechanisms.
                                                                                                                                                                      ^
Main.java:35: error: illegal character: '#'
### Practical Implementation Toolkit for Professionals
^
Main.java:35: error: illegal character: '#'
### Practical Implementation Toolkit for Professionals
 ^
Main.java:35: error: illegal character: '#'
### Practical Implementation Toolkit for Professionals
  ^
Main.java:37: error: illegal character: '\u2011'
Prescribing ground?toadstool supplements begins with a baseline assessment: CBC, liver panel, and cytokine profile establish a reference point. Eligibility criteria exclude individuals with known mushroom allergy, active autoimmune flare, or pregnancy.
                  ^
Main.java:39: error: illegal character: '\u2014'
The dosing protocol recommends 500 mg of standardized extract twice daily, titrated up to 1 g per dose after four weeks if tolerated. A checklist?contraindications, baseline labs, informed?consent aligned with GDPR?ensures regulatory compliance and patient safety.
                                                                                                                                                 ^
Main.java:39: error: illegal character: '\u2011'
The dosing protocol recommends 500 mg of standardized extract twice daily, titrated up to 1 g per dose after four weeks if tolerated. A checklist?contraindications, baseline labs, informed?consent aligned with GDPR?ensures regulatory compliance and patient safety.
                                                                                                                                                                                            ^
Main.java:39: error: illegal character: '\u2014'
The dosing protocol recommends 500 mg of standardized extract twice daily, titrated up to 1 g per dose after four weeks if tolerated. A checklist?contraindications, baseline labs, informed?consent aligned with GDPR?ensures regulatory compliance and patient safety.
                                                                                                                                                                                                                      ^
Main.java:41: error: illegal character: '\u2011'
Monitoring follows a monthly review template capturing symptom scores, CRP trends, and adverse?event logs. Decision trees guide dose escalation or discontinuation, allowing clinicians to adapt therapy based on objective biomarkers and subjective well?being reports.
                                                                                              ^
Main.java:41: error: illegal character: '\u2011'
Monitoring follows a monthly review template capturing symptom scores, CRP trends, and adverse?event logs. Decision trees guide dose escalation or discontinuation, allowing clinicians to adapt therapy based on objective biomarkers and subjective well?being reports.
                                                                                                                                                                                                                                                          ^
Main.java:43: error: illegal character: '#'
### Integration with AmanitaCare?s Digital Ecosystem
^
Main.java:43: error: illegal character: '#'
### Integration with AmanitaCare?s Digital Ecosystem
 ^
Main.java:43: error: illegal character: '#'
### Integration with AmanitaCare?s Digital Ecosystem
  ^
Main.java:43: error: illegal character: '\u2019'
### Integration with AmanitaCare?s Digital Ecosystem
                                ^
Main.java:45: error: illegal character: '\u2019'
AmanitaCare?s portal automates enrolment, baseline data capture, and supplement dispatch. An API endpoint imports laboratory results in real time, while a patient?report module feeds adherence and outcome metrics into a clinician dashboard.
           ^
Main.java:45: error: illegal character: '\u2011'
AmanitaCare?s portal automates enrolment, baseline data capture, and supplement dispatch. An API endpoint imports laboratory results in real time, while a patient?report module feeds adherence and outcome metrics into a clinician dashboard.
                                                                                                                                                                  ^
Main.java:47: error: illegal character: '\u2192'
The workflow proceeds as: patient enrolment ? baseline assessment ? supplement shipment ? automated reminders ? data sync ? clinician review. This closed loop reduces administrative overhead and supports evidence generation for ROI calculations.
                                            ^
Main.java:47: error: illegal character: '\u2192'
The workflow proceeds as: patient enrolment ? baseline assessment ? supplement shipment ? automated reminders ? data sync ? clinician review. This closed loop reduces administrative overhead and supports evidence generation for ROI calculations.
                                                                  ^
Main.java:47: error: illegal character: '\u2192'
The workflow proceeds as: patient enrolment ? baseline assessment ? supplement shipment ? automated reminders ? data sync ? clinician review. This closed loop reduces administrative overhead and supports evidence generation for ROI calculations.
                                                                                        ^
Main.java:47: error: illegal character: '\u2192'
The workflow proceeds as: patient enrolment ? baseline assessment ? supplement shipment ? automated reminders ? data sync ? clinician review. This closed loop reduces administrative overhead and supports evidence generation for ROI calculations.
                                                                                                              ^
Main.java:47: error: illegal character: '\u2192'
The workflow proceeds as: patient enrolment ? baseline assessment ? supplement shipment ? automated reminders ? data sync ? clinician review. This closed loop reduces administrative overhead and supports evidence generation for ROI calculations.
                                                                                                                          ^
Main.java:49: error: illegal character: '\u2011'
KPI recommendations include adherence rate (>85 %), adverse?event incidence (
                                                           ^
Main.java:55: error: illegal character: '\u2011'
- Neuro?cognitive gains such as increased BDNF, higher energy scores, and reduced perceived stress.
       ^
Main.java:59: error: illegal character: '\u2011'
- Digital integration via AmanitaCare enables real?time monitoring, high adherence, and clear ROI metrics.
                                                  ^
Main.java:61: error: illegal character: '\u2011'
- Future research aims to fill long?term safety gaps and expand market share across Europe./* package whatever; // don't place package name! */
                                   ^
72 errors

Standard output is empty